SCOPUS 정보 검색 플랫폼

European Journal of Pharmaceutical Sciences

Volumn 13, Issue 2, 2001, Pages 115-122

Role of modelling and simulation in Phase I drug development

(6) Aarons, L a Karlsson, M O a Mentre, F a Rombout, F a Steimer, J L a Van Peer, A a

a UPPSALA UNIVERSITY (Sweden)

Author keywords

Drug development; Pharmacokinetic and pharmacodynamic modelling; Phase I clinical trials

Indexed keywords

BIOASSAY; BIOMARKERS; COMPUTER SIMULATION; DECISION MAKING; DRUG DOSAGE; PERSONNEL TRAINING;

DRUG DEVELOPMENT;

DRUG PRODUCTS;

DRUG DEVELOPMENT; MODEL; PHARMACODYNAMICS; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; POPULATION MODEL; PREDICTION; PRIORITY JOURNAL; REVIEW; SIMULATION;

CLINICAL TRIALS, PHASE I; COMPUTER SIMULATION; DRUG DESIGN; HUMANS; MODELS, BIOLOGICAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHARMACOKINETICS; RESEARCH DESIGN;

EID: 0035070215 PISSN: 09280987 EISSN: None Source Type: Journal
DOI: 10.1016/S0928-0987(01)00096-3 Document Type: Article

Times cited : (95)

References (32)

1
- 0026691811
- Plasma concentration-effect relationships for felodipine: a meta analysis
- (1992) Clin. Pharmacol. Ther. , vol.52 , pp. 80-89
- Blychert, E.¹ Edgar, B.² Elmfeldt, D.³ Hedner, T.⁴

2
- 0028985925
- The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion
- (1995) Cancer Chemother. Pharmacol. , vol.36 , pp. 53-60
- Boddy, A.V.¹ Cole, M.² Pearson, A.D.³ Idle, J.R.⁴

3
- 0030890279
- Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development: the 'wooden shoe' paradigm
- (1997) Clin. Pharmacokinet. , vol.32 , pp. 259-267
- Breimer, D.D.¹ Danhof, M.²

4
- 0029549676
- Physiologically based pharmacokinetic modeling as a tool for drug development
- (1995) J. Pharamacokinet. Biopharm. , vol.23 , pp. 217-229
- Charnick, S.B.¹ Kawai, R.² Nedelman, J.R.³ Lemaire, M.⁴ Niederberger, W.⁵ Sato, H.⁶

5
- 0005445131
- Danhof M., Steimer J.L. (Eds.), Measurement and Kinetics of in Vivo Drug Effects, The Netherlands: Leiden/Amsterdam Center for Drug Research
- (1998) Advances in Simultaneous Pharmacokinetic/pharmacodynamic Modeling

6
- 0030132584
- Structure-function relationship of recombinant follicle stimulating hormone (Puregon)
- (1996) Mol. Hum. Reprod. , vol.2 , pp. 361-369
- de Leeuwe, R.¹ Mulders, J.² Voortman, G.³ Rombout, F.⁴ Damm, J.⁵ Kloosterboer, L.⁶

7
- 0032974197
- Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives
- (1999) Pharm. Res. , vol.16 , pp. 176-185
- Derendorf, H.¹ Meibohm, B.²

8
- 85001825674
- An Introduction to the Bootstrap, New York: Chapman and Hall
- (1993)
- Efron, B.¹ Tibshirani, T.J.²

9
- 0029973997
- Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide
- (1996) Am. J. Physiol. , vol.271 , pp. E775-E787
- Fattinger, K.E.¹ Verotta, D.² Porchet, H.C.³ Munafo, A.⁴ Le Cotonnec, J.Y.⁵ Sheiner, L.B.⁶

10
- 0027750786
- A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers
- (1993) J. Pharmacokinet. Biopharm. , vol.21 , pp. 489-514
- Francheteau, P.¹ Steimer, J.L.² Merdjan, H.³ Guerret, M.⁴ Dubray, C.⁵

11
- 0032424543
- A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride
- (1998) Clin. Pharmacol. Ther. , vol.64 , pp. 636-647
- Gisleskog, P.O.¹ Hermann, D.² Hammarlund-Udenaes, M.³ Karlsson, M.O.⁴

12
- 0032945558
- The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination
- (1999) Br. J. Clin. Pharmacol. , vol.47 , pp. 53-58
- Gisleskog, P.O.¹ Hermann, D.² Hammarlund-Udenaes, M.³ Karlsson, M.O.⁴

13
- 0032708007
- A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients
- (1999) Br. J. Clin. Pharmacol. , vol.48 , pp. 669-677
- Hassan, M.¹ Svensson, U.S.² Ljungman, P.³ Bjorkstrand, B.⁴ Olsson, H.⁵ Bielenstein, M.⁶ Abdel-Rehim, M.⁷ Nilsson, C.⁸ Johansson, M.⁹ Karlsson, M.O.¹⁰

14
- 85001628299
- Holford, N.H.G., Hale, M., Ko, H.C., Steimer, J-L., Sheiner L.B., Peck, C.C., 2000a. Simulation in drug development: Good practices. http://www.dml.georgetown.edu/cdds

15
- 0034074181
- Simulation of clinical trials
- (2000) Annu. Rev. Pharmacol. Toxicol. , vol.40 , pp. 209-234
- Holford, N.H.G.¹ Kimko, H.C.² Monteleone, J.P.R.³ Peck, C.C.⁴

16
- 85001563131
- ICH, 1997. ICH Consensus Guideline on General Considerations for Clinical Trials. CPMP/ICH/291/95, July 1997

17
- 4243904570
- Determination of relative potency for drug and metabolite in vivo
- PAGE Conference, Frankfurt, http://userpage.fu-berlin.de/˜page/
- (1996)
- Karlsson, M.O.¹ Milligan, P.² Nichols, D.³

18
- 0026079187
- Pharmacodynamic modeling. Application to new drug development
- (1991) Clin. Pharmacokinet. , vol.20 , pp. 91-98
- Kroboth, P.D.¹ Schmith, V.D.² Smith, R.B.³

19
- 0030641551
- Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application
- (1997) Anesthesiology , vol.86 , pp. 24-33
- Minto, C.F.¹ Schnider, T.W.² Shafer, S.L.³

20
- 85001639995
- Application of population analysis in phase I/II clinical drug development
- Aarons L., Balant L.P., Gundert-Remy U.A., Karlsson M.O., Mentré F., Morselli P.L., Rombout F., Rowland M., Steimer J.L., Vozeh S. (Eds.), The Population Approach: Measuring and Managing Variability in Response, Concentration and Dose, Luxembourg: Office for Official Publications of the European Communities
- (1997) , pp. 217-225
- Nichols, D.J.¹ Milligan, P.A.² Jonsson, E.N.³ Karlsson, M.O.⁴

21
- 0032454220
- Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile
- (1998) J. Pharmacokinet. Biopharm. , vol.26 , pp. 471-492
- Park, K.¹ Verotta, D.² Gupta, S.K.³ Sheiner, L.B.⁴

22
- 0030849120
- An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffman La Roche
- (1997) Clin. Pharmacokinet. , vol.33 , pp. 142-152
- Reigner, B.G.¹ Williams, P.E.O.² Patel, I.H.³ Steimer, J.L.⁴ Peck, C.⁵ van Brummelen, P.⁶

23
- 0000688072
- Good pharmacokinetic practice (GPP) and logistics: a continuing challenge
- Aarons L., Balant L.P., Gundert-Remy U.A., Karlsson M.O., Mentré F., Morselli P.L., Rombout F., Rowland M., Steimer J.L., Vozeh S. (Eds.), The Population Approach: Measuring and Managing Variability in Response, Concentration and Dose, Luxembourg: Commission of the European Community
- (1997) , pp. 183-193
- Rombout, F.¹

24
- 4243863377
- Is there a rational for bioequivalence testing for endogenous compounds
- Bioequivalence or Biocomparability of Complex Molecules, September 14-15, Toronto, Canada
- (1996)
- Rombout, F.¹

25
- 85001614452
- Rowland M., Aarons L. (Eds.), New Strategies in Drug Development and Clinical Evaluation: The Population Approach, Luxembourg: Commission of the European Community
- (1992)

26
- 0030931325
- Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective
- (1997) Clin. Pharmacokinet. , vol.32 , pp. 294-312
- Samara, E.¹ Granneman, R.²

27
- 0029839379
- Estimating impossible curves using NONMEM
- (1996) Br. J. Clin. Pharmacol. , vol.42 , pp. 283-290
- Schoemaker, R.C.¹ Cohen, A.F.²

28
- 0031003468
- Learning versus confirming in clinical drug development
- (1997) Clin. Pharmacol. Ther. , vol.61 , pp. 275-291
- Sheiner, L.B.¹

29
- 0034119297
- Pharmacokinetic/pharmacodynamic modeling in drug development
- (2000) Annu. Rev. Pharmacol. Toxicol. , vol.40 , pp. 67-95
- Sheiner, L.B.¹ Steimer, J.L.²

30
- 0003104128
- Predicting the optimal dose of saquinavir via modelling of dose-exposure and exposure-effect relationships
- Danhof M., Steimer J. (Eds.), Measurement and Kinetics of in Vivo Drug Effects, The Netherlands: Leiden/Amsterdam Center for Drug Research
- (1998) Advances in Simultaneous Pharmacokinetic/Pharmacodynamic Modelling , pp. 79-86
- Steimer, J.¹ Fotteler, B.² Gieschke, R.³ Wiltshire, H.⁴ Buss, N.⁵

31
- 0032769235
- Population pharmacokinetics. A regulatory perspective
- (1999) Clin. Pharmacokinet. , vol.37 , pp. 41-58
- Sun, H.¹ Fadiran, E.O.² Jones, C.D.³ Lesko, L.⁴ Huang, S.M.⁵ Higgins, K.⁶ Hu, C.P.⁷ Machado, S.⁸ Maldonado, S.⁹ Williams, R.¹⁰ Hossain, M.¹¹ Ette, E.I.¹²

32
- 0027256031
- Pharmacokinetic-pharmacodynamic relationships in Phase I/Phase II of drug development
- (1993) Eur. J. Drug Metab. Pharmacokinet. , vol.18 , pp. 49-59
- Van Peer, A.¹ Snoeck, E.² Huang, M.L.³ Heykants, J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.